Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
मुख्य लेखक: | Paul, Pulock |
---|---|
अन्य लेखक: | Azam,Faruque |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
Brac University
2024
|
विषय: | |
ऑनलाइन पहुंच: | http://hdl.handle.net/10361/23954 |
समान संसाधन
-
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
द्वारा: Rahman, Tasnim
प्रकाशित: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
द्वारा: Hoque, Ismoth Ara
प्रकाशित: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
द्वारा: Karim, Samia Binte
प्रकाशित: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
द्वारा: Flora, Sanzida Alam
प्रकाशित: (2024) -
A review on targeted therapies for lung cancer
द्वारा: Ashraf, Anushey
प्रकाशित: (2023)